{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:39:55Z","timestamp":1788716395446,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]},{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]},{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]},{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]},{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]},{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]},{"name":"German Federal Ministry of Health","award":["ZMI1-2521GHP906"],"award-info":[{"award-number":["ZMI1-2521GHP906"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>In the World Health Organization European Region, an estimated 14\u00a0million people live with a chronic hepatitis B virus infection (HBV), and 12\u00a0million are affected by a hepatitis C virus infection (HCV). Uzbekistan bears a major burden of HBV and has one of the highest HCV prevalence in the region. Following a presidential decree in May 2022, significant funds were allocated to the viral hepatitis (VH) elimination program in Uzbekistan. The program expands VH testing to reach 500,000 people annually during 2022\u20132025 as part of the VH elimination strategy that includes the provision of free testing and affordable treatment. Exploring the existing barriers and facilitators to VH testing is pivotal for informing these interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study uses a cross-sectional qualitative design to identify and explore the barriers and facilitators to VH testing among the general population in Uzbekistan. We collected data during October-November 2022 through semi-structured interviews with 12 key informants (KIs) and 7 focus group discussions with two target populations: the general population and healthcare workers (HCW) in Tashkent, Uzbekistan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Following the capability-opportunity-motivation-behavior model (COM-B model) as a framework for the analysis, we identified major capability barriers to VH testing primarily linked to low health literacy and limited knowledge about VH types, symptoms, transmission, testing and treatment. Physical opportunity barriers included the time and financial costs associated with testing, diagnostics, and treatment. Sociocultural opportunity barriers involved anticipated negative reactions and stigmatization, particularly affecting women. Motivational barriers included a reluctance to be tested when asymptomatic and a general fear of receiving positive test results. The involvement of healthcare workers in promoting VH awareness and motivating the general population emerged as a facilitator.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A multi-pronged approach is recommended to achieve VH testing goals among the general population, focusing on raising awareness and health literacy and creating an enabling environment that ensures easy accessibility and minimizing VH testing-associated costs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-18953-5","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T07:02:40Z","timestamp":1717398160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population"],"prefix":"10.1186","volume":"24","author":[{"given":"Alyona","family":"Mazhnaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brogan","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krestina","family":"Brigida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokhista","family":"Bakieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakhlo","family":"Sadirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Witzigmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin","family":"Musabaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heide","family":"Weishaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dudareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel El","family":"Bcheraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"1","key":"18953_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12(1):145. https:\/\/doi.org\/10.1186\/s12916-014-0145-y","journal-title":"BMC Med"},{"key":"18953_CR2","unstructured":"WHO, Hepatitis, C in the WHO European Region - factsheet July. 2022. World Health Organization. Published 2023. Accessed July 24, 2023. https:\/\/www.who.int\/europe\/publications\/m\/item\/hepatitis-c-in-the-who-european-region-factsheet-july-2022"},{"key":"18953_CR3","unstructured":"WHO, Hepatitis, B in the WHO European Region - factsheet July. 2022. World Health Organization. Published 2023. Accessed July 24, 2023. https:\/\/www.who.int\/europe\/publications\/m\/item\/hepatitis-b-in-the-who-european-region-factsheet-july-2022"},{"issue":"2","key":"18953_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhepr.2019.04.002","volume":"1","author":"S Smith","year":"2019","unstructured":"Smith S, Harmanci H, Hutin Y, et al. Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO member state responses 2017. JHEP Rep. 2019;1(2):81\u20139. https:\/\/doi.org\/10.1016\/j.jhepr.2019.04.002","journal-title":"JHEP Rep"},{"issue":"4","key":"18953_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/LIV.15514","volume":"43","author":"E Musabaev","year":"2023","unstructured":"Musabaev E, Estes C, Sadirova S, et al. Viral hepatitis elimination challenges in low- and middle-income countries\u2014Uzbekistan hepatitis elimination program (UHEP). Liver Int. 2023;43(4):773\u201384. https:\/\/doi.org\/10.1111\/LIV.15514","journal-title":"Liver Int"},{"key":"18953_CR6","doi-asserted-by":"publisher","unstructured":"Botheju WSP, Zghyer F, Mahmud S, Terlikbayeva A, El-Bassel N, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Central Asia: systematic review, meta-analyses, and meta-regression analyses. Sci Rep. 2019;9(1). https:\/\/doi.org\/10.1038\/S41598-019-38853-8","DOI":"10.1038\/S41598-019-38853-8"},{"issue":"6","key":"18953_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000050066","volume":"44","author":"R Ruzibakiev","year":"2001","unstructured":"Ruzibakiev R, Kato H, Ueda R, et al. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan. Intervirology. 2001;44(6):327\u201332. https:\/\/doi.org\/10.1159\/000050066","journal-title":"Intervirology"},{"key":"18953_CR8","unstructured":"Regional action plans for. ending AIDS and the epidemics of viral hepatitis and sexually transmitted infections 2022\u20132030. Accessed April 29, 2024. https:\/\/iris.who.int\/handle\/10665\/369243"},{"key":"18953_CR9","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. Published online 2016. Accessed July 24. 2023. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/who?sequence=1"},{"key":"18953_CR10","unstructured":"WHO. Action plan for the health sector response to viral hepatitis in the WHO European Region. Published online 2017. Accessed July 24. 2023. https:\/\/apps.who.int\/iris\/handle\/10665\/344154"},{"key":"18953_CR11","unstructured":"Decree of the President of the Republic of Uzbekistan On improving measures to counteract the spread of certain topical viral infections [PQ-243-\u0441\u043e\u043d 16.05.2022. Ayrim dolzarb virusli infeksiyalar tarqalishiga qarshi kurashish chora-tadbirlarini takomillashtirish to\u2018g\u2018risida]. Published 2022. Accessed October 2. 2023. https:\/\/lex.uz\/uz\/docs\/-6017442"},{"key":"18953_CR12","unstructured":"WHO. Scaling up hepatitis response in Uzbekistan. Published 2022. Accessed September 26, 2023. https:\/\/www.who.int\/europe\/news\/item\/28-07-2022-scaling-up-hepatitis-response-in-uzbekistan"},{"key":"18953_CR13","doi-asserted-by":"publisher","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1). https:\/\/doi.org\/10.1186\/1748-5908-6-42","DOI":"10.1186\/1748-5908-6-42"},{"key":"18953_CR14","first-page":"1010","volume":"1003","author":"S Michie","year":"2014","unstructured":"Michie S, Atkins L, West R. The behaviour change wheel. A guide to designing interventions 1. Great Britain: Silverback Publishing. 2014;1003:1010.","journal-title":"Great Britain: Silverback Publishing"},{"key":"18953_CR15","unstructured":"WHO. A Guide to Tailoring Health Programmes: Using Behavioural and Cultural Insights to Tailor Health Policies, Services and Communications to the Needs and Circumstances. 2023. Accessed July 24, 2023. https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289058919"},{"issue":"1","key":"18953_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00103-019-03063-0","volume":"63","author":"KB Habersaat","year":"2020","unstructured":"Habersaat KB, Jackson C. Understanding vaccine acceptance and demand\u2014and ways to increase them. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020;63(1):32\u20139. https:\/\/doi.org\/10.1007\/s00103-019-03063-0","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"1","key":"18953_CR17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12887-022-03687-3","volume":"22","author":"C Jackson","year":"2022","unstructured":"Jackson C, Nielsen SM, Simonyan B, et al. Medical specialists\u2019 attitudes and practices towards childhood vaccination: a qualitative study in Armenia. BMC Pediatr. 2022;22(1):620. https:\/\/doi.org\/10.1186\/s12887-022-03687-3","journal-title":"BMC Pediatr"},{"issue":"8","key":"18953_CR18","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.vaccine.2020.01.025","volume":"38","author":"S Musa","year":"2020","unstructured":"Musa S, Skrijelj V, Kulo A, et al. Identifying barriers and drivers to vaccination: a qualitative interview study with health workers in the Federation of Bosnia and Herzegovina. Vaccine. 2020;38(8):1906\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.025","journal-title":"Vaccine"},{"issue":"6","key":"18953_CR19","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/HEX.13346","volume":"24","author":"B O\u2019Donovan","year":"2021","unstructured":"O\u2019Donovan B, Mooney T, Rimmer B, et al. Advancing understanding of influences on cervical screening (non)-participation among younger and older women: a qualitative study using the theoretical domains framework and the COM-B model. Health Expect. 2021;24(6):2023\u201335. https:\/\/doi.org\/10.1111\/HEX.13346","journal-title":"Health Expect"},{"issue":"4","key":"18953_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/BS12040108","volume":"12","author":"SB Garcia","year":"2022","unstructured":"Garcia SB, Cha\u0142upnik M, Irving K, Haselgrove M. Increasing condom use and STI testing: creating a behaviourally informed sexual healthcare campaign using the COM-B model of behaviour change. Behav Sci 2022. 2022;12(4):108. https:\/\/doi.org\/10.3390\/BS12040108","journal-title":"Behav Sci 2022"},{"issue":"3","key":"18953_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/jvh.13443","volume":"28","author":"D Whiteley","year":"2020","unstructured":"Whiteley D, Speakman E, Elliott L, et al. Provider-related barriers and enablers to the provision of hepatitis C treatment by general practitioners in Scotland: a behaviour change analysis. J Viral Hepat. 2020;28(3):528\u201337. https:\/\/doi.org\/10.1111\/jvh.13443","journal-title":"J Viral Hepat"},{"key":"18953_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/PPA.S285442","volume":"15","author":"P Mishra","year":"2021","unstructured":"Mishra P, Vamadevan AS, Roy A, et al. Exploring barriers to medication adherence using com-b model of behaviour among patients with cardiovascular diseases in low-and middle-income countries: a qualitative study. Patient Prefer Adherence. 2021;15:1359\u201371. https:\/\/doi.org\/10.2147\/PPA.S285442","journal-title":"Patient Prefer Adherence"},{"key":"18953_CR23","unstructured":"Jackson C, Eliasson L, Barber N, Weinman J, Applying. COM-B to medication adherence: a suggested framework for research and interventions. The European Health Psychologist. 2014;16(1):7\u201317. Accessed April 17, 2024. https:\/\/www.ehps.net\/ehp\/index.php\/contents\/article\/download\/ehp.v16.i1.p7\/1072"},{"key":"18953_CR24","unstructured":"WHO. European Regional Action Framework for Behavioural and Cultural Insights for Health, 2022\u20132027. 2023. Accessed May 5, 2024. https:\/\/pesquisa.bvsalud.org\/portal\/resource\/pt\/who-372664"},{"key":"18953_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.socscimed.2017.07.029","volume":"189","author":"GA Johnson","year":"2017","unstructured":"Johnson GA, Vindrola-Padros C. Rapid qualitative research methods during complex health emergencies: a systematic review of the literature. Soc Sci Med. 2017;189:63\u201375. https:\/\/doi.org\/10.1016\/j.socscimed.2017.07.029","journal-title":"Soc Sci Med"},{"issue":"14","key":"18953_CR26","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1177\/1049732320951526","volume":"30","author":"C Vindrola-Padros","year":"2020","unstructured":"Vindrola-Padros C, Chisnall G, Cooper S, et al. Carrying out rapid qualitative research during a pandemic: emerging lessons from COVID-19. Qual Health Res. 2020;30(14):2192\u2013204. https:\/\/doi.org\/10.1177\/1049732320951526","journal-title":"Qual Health Res"},{"key":"18953_CR27","unstructured":"WHO. Rapid Qualitative Research to Increase COVID-19 Vaccination Uptake: A Research and Intervention Tool. 2022. Accessed July 24, 2023. https:\/\/apps.who.int\/iris\/handle\/10665\/351117"},{"key":"18953_CR28","unstructured":"WHO. Health promotion glossary of terms 2021. Published online 2021. Accessed July 24. 2023. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/350161\/9789240038349-eng.pdf"},{"key":"18953_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.SOCSCIMED.2014.03.022","volume":"110","author":"GR Bauer","year":"2014","unstructured":"Bauer GR. Incorporating intersectionality theory into population health research methodology: challenges and the potential to advance health equity. Soc Sci Med. 2014;110:10\u20137. https:\/\/doi.org\/10.1016\/J.SOCSCIMED.2014.03.022","journal-title":"Soc Sci Med"},{"key":"18953_CR30","doi-asserted-by":"publisher","first-page":"1118227","DOI":"10.3389\/fpubh.2023.1118227","volume":"11","author":"CPB Moonen","year":"2023","unstructured":"Moonen CPB, den Heijer CDJ, Dukers-Muijrers NHTM, van Dreumel R, Steins SCJ, Hoebe CJPA. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU\/EEA region. Front Public Health. 2023;11:1118227. https:\/\/doi.org\/10.3389\/fpubh.2023.1118227","journal-title":"Front Public Health"},{"issue":"1","key":"18953_CR31","doi-asserted-by":"publisher","first-page":"ofad002","DOI":"10.1093\/ofid\/ofad002","volume":"10","author":"M Khalili","year":"2023","unstructured":"Khalili M, Kim NJ, Tsoh JY, et al. Efficacy of a primary care-based mobile application to increase hepatitis C screening among Asian americans: a secondary analysis of a randomized clinical trial. Open Forum Infect Dis. 2023;10(1):ofad002. https:\/\/doi.org\/10.1093\/ofid\/ofad002","journal-title":"Open Forum Infect Dis"},{"key":"18953_CR32","doi-asserted-by":"publisher","unstructured":"Brewer N, DeFrank J, Psychology MGH. 2016 undefined. Anticipated regret and health behavior: A meta-analysis. psycnet.apa.org. Published online 2016. https:\/\/doi.org\/10.1037\/hea0000294","DOI":"10.1037\/hea0000294"},{"issue":"7\u20138","key":"18953_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.14745\/CCDR.V44I78A03","volume":"44","author":"N Shehata","year":"2018","unstructured":"Shehata N, Austin T, Ha S, Timmerman K. Can we eliminate hepatitis C? Barriers to and facilitators of hepatitis C virus screening and testing: a scoping review. Can Commun Dis Rep. 2018;44(7\u20138):166. https:\/\/doi.org\/10.14745\/CCDR.V44I78A03","journal-title":"Can Commun Dis Rep"},{"key":"18953_CR34","doi-asserted-by":"publisher","first-page":"113739","DOI":"10.1016\/j.socscimed.2021.113739","volume":"273","author":"A Antinyan","year":"2021","unstructured":"Antinyan A, Bertoni M, Corazzini L. Cervical cancer screening invitations in low and middle income countries: evidence from Armenia. Soc Sci Med. 2021;273:113739. https:\/\/doi.org\/10.1016\/j.socscimed.2021.113739","journal-title":"Soc Sci Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18953-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T07:04:23Z","timestamp":1717398263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18953-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18953"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18953-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ministry of Health of the Republic of Uzbekistan Ethical Committee reviewed and approved the study on November 4th, 2022 (minutes of the meeting #7\/2-1706). All KIs and FGDs participants provided written and verbal informed consent before data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1482"}}